Salim Yazji
2021
In 2021, Salim Yazji earned a total compensation of $2M as Chief Medical Officer at GTX.
Compensation breakdown
| Non-Equity Incentive Plan | $88,140 |
|---|---|
| Option Awards | $1,662,770 |
| Salary | $264,518 |
| Total | $2,015,428 |
Yazji received $1.7M in option awards, accounting for 83% of the total pay in 2021.
Yazji also received $88.1K in non-equity incentive plan and $264.5K in salary.
Rankings
In 2021, Salim Yazji's compensation ranked 6,023rd out of 12,415 executives tracked by ExecPay. In other words, Yazji earned more than 51.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,023 out of 12,415 | 52nd |
Division Manufacturing | 2,549 out of 5,508 | 54th |
Major group Chemicals And Allied Products | 1,115 out of 2,378 | 53rd |
Industry group Drugs | 993 out of 2,099 | 53rd |
Industry Pharmaceutical Preparations | 715 out of 1,549 | 54th |
Source: SEC filing on April 29, 2022.
Yazji's colleagues
We found two more compensation records of executives who worked with Salim Yazji at GTX in 2021.